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The conserved Myc box 2 and Myc box 3 regions are important,
but not essential, for Myc function in vivo
Abstract
Myc proto-oncoproteins are important regulators of growth and proliferation in development. Their
functions have been evolutionarily conserved from insects to vertebrates, although the sequence
conservation is limited to a few short domains. Here, we analyze the requirement for the most highly
conserved domains, called Myc boxes 2 and 3 (MB2 and MB3), and for the weakly conserved
N-terminus for the biological activity of the single Drosophila Myc protein in the animal in vivo. We
find that a Myc mutant lacking the N-terminus retains very little activity, whereas Myc transgenes
carrying a deletion of MB3 have a moderately increased ability to promote growth and apoptosis;
mutation of MB2 reduces transcriptional output and the biological activities of Myc. Surprisingly
though, Myc without MB2 retains enough activity to partially rescue the lethality of a Myc null
mutation. Thus, although MB2 and MB3 are highly conserved in evolution, loss of either domain has
comparatively  mild consequences on Myc activity in vivo.
 1 
Gene 436 (2009), 90 – 100 
The conserved Myc box 2 and Myc box 3 regions are important, but not 
essential, for Myc function in vivo  
D.Schwinkendorf & P.Gallant1 
Zoologisches Institut, Universität Zürich, Winterthurerstrasse 190, CH-8057 Zürich, Switzerland 
1 author for correspondence: gallant@zool.uzh.ch, +41446354812 
Running title: In vivo structure-function analysis of Myc 
Keywords: growth, apoptosis, transcription 
 
 
doi:10.1016/j.gene.2009.02.009 
 2 
Abstract 
Myc proto-oncoproteins are important regulators of growth and proliferation in development. Their 
functions have been evolutionarily conserved from insects to vertebrates, although the sequence 
conservation is limited to a few short domains. Here, we analyze the requirement for the most highly 
conserved domains, called Myc boxes 2 and 3 (MB2 and MB3), and for the weakly conserved N-terminus 
for the biological activity of the single Drosophila Myc protein in the animal in vivo. We find that a Myc 
mutant lacking the N-terminus retains very little activity, whereas Myc transgenes carrying a deletion of 
MB3 have a moderately increased ability to promote growth and apoptosis; mutation of MB2 reduces 
transcriptional output and the biological activities of Myc. Surprisingly though, Myc without MB2 retains 
enough activity to partially rescue the lethality of a Myc null mutation. Thus, although MB2 and MB3 are 
highly conserved in evolution, loss of either domain has comparatively mild consequences on Myc 
activity in vivo. 
 3 
1 Introduction 
Myc has been identified as a proto-oncogene that is frequently mutated and overexpressed in human 
and animal cancers (reviewed by Oster et al., 2002). During normal development and tissue homeostasis, 
Myc controls several cellular processes, most prominently growth, proliferation and apoptosis (de la Cova 
and Johnston, 2006; Pirity et al., 2006). These different activities of Myc have been attributed to its 
ability to stimulate or repress the transcription of many target genes (reviewed by Grandori et al., 2000; 
Amati et al., 2001; Dang et al., 2006). Up to 15% of all genes are modulated by Myc proteins (Fernandez 
et al., 2003; Orian et al., 2003), including genes transcribed by RNA polymerases I and III. However, 
most of its targets are only moderately affected by Myc (reviewed by Dang et al., 2006). In addition, Myc 
has transcription-independent roles in the control of DNA replication (Dominguez-Sola et al., 2007). 
To molecularly understand how Myc controls its target genes and what might distinguish Myc from 
other transcription factors, several structure/function analyzes of Myc have been carried out. Myc’s best 
understood domain, and the only one for which structural information is available (Nair and Burley, 
2003), is the C-terminal basic-helix-loop-helix-leucine zipper region (BHLHZ) which serves as a 
dimerization interface with a protein called Max (Blackwood and Eisenman, 1991) and also mediates the 
contact of Myc:Max heterodimers with DNA. In addition, several other proteins have been shown to 
contact this C-terminus (reviewed by Cowling and Cole, 2006). This region is generally assumed to be 
essential for all of Myc’s activities, although recent reports suggest the existence of some C-terminus 
independent functions of Myc (Cowling and Cole, 2007; Steiger et al., 2008).  
Myc’s N-terminal 143 amino acids contain a transcriptional regulatory domain (Kato et al., 1990) that 
interacts with different co-factors, such as TRRAP, a component of several histone acetyltransferase 
(HAT) complexes (McMahon et al., 1998), the STAGA HAT (McMahon et al., 2000; Liu et al., 2003; 
Liu et al., 2008), the DNA helicases Tip48 and Tip49 that also belong to different HAT and chromatin 
remodeling complexes (Wood et al., 2000), and the elongation factor P-TEFb (Eberhardy and Farnham, 
2002). Accordingly, a version of c-Myc that lacks the first 100 amino acids is inefficient in trans-
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activating its target genes (Spotts et al., 1997; Xiao et al., 1998; Hirst and Grandori, 2000), and it is 
unable to transform primary cells in culture (Xiao et al., 1998) or promote cell cycle re-entry of serum-
starved fibroblasts (Hirst and Grandori, 2000). Surprisingly, though, such a truncated c-Myc protein 
retains substantial biological activity: it induces apoptosis in response to limitation of survival factors 
(Xiao et al., 1998), stimulates the rate of proliferation of exponentially growing fibroblasts (Hirst and 
Grandori, 2000), even in the complete absence of endogenous c-Myc (Xiao et al., 1998), and it can rescue 
a lethal mutation of the only Drosophila Myc gene, dmPG45 (Benassayag et al., 2005). 
These properties contrast with those of a short motif called Myc box 2 (MB2) that is located between 
amino acids 128 and 143 in human c-Myc. The MB2 sequence is unique to Myc and evolutionarily 
highly conserved in all Myc proteins, down to invertebrates (reviewed in Gallant, 2006). Elimination of 
MB2 blocks or severely impairs all of Myc’s biological activities that have been tested in cultured cells: 
the ability to promote cellular proliferation (Lee et al., 1997; Conzen et al., 2000; Hirst and Grandori, 
2000; Kenney et al., 2003), apoptosis (Evan et al., 1992; Conzen et al., 2000; Dugan et al., 2002; Oster et 
al., 2003; Cowling et al., 2006), transformation (Sarid et al., 1987; Stone et al., 1987; Li et al., 1994; 
Brough et al., 1995; McMahon et al., 1998; Conzen et al., 2000; McMahon et al., 2000; Nikiforov et al., 
2002; Oster et al., 2003; Cowling et al., 2006), and block differentiation (Freytag et al., 1990). 
Furthermore, an MB2-mutant Myc very inefficiently rescues the proliferation defect of rat fibroblasts 
lacking endogenous c-Myc (Bush et al., 1998; Xiao et al., 1998; Nikiforov et al., 2002; Oster et al., 
2003). The MB2 motif is required for the efficient interaction with several co-factors such as TRRAP and 
associated HATs (McMahon et al., 1998; Bouchard et al., 2001; Frank et al., 2001; Nikiforov et al., 
2002), the HAT complex component BAF53 (Park et al., 2002), TIP48 & TIP49 (Wood et al., 2000), 
Skp2 (Kim et al., 2003; von der Lehr et al., 2003), and for the stimulation of pre-mRNA capping 
(Cowling and Cole, 2007). Nevertheless, it has been shown that a Myc mutant lacking MB2 still 
efficiently activates the expression of some target genes and artificial reporters (Kato et al., 1990; Bello-
Fernandez et al., 1993; Li et al., 1994; Brough et al., 1995; Lee et al., 1997; Xiao et al., 1998; Nikiforov 
et al., 2002), although many targets are only poorly activated by such a protein (Conzen et al., 2000; Hirst 
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and Grandori, 2000; Bouchard et al., 2001; Nikiforov et al., 2002; Kenney et al., 2003; Cowling et al., 
2006; Cowling and Cole, 2007). Such a MycΔMB2 mutant also fails to repress the genes that are 
normally down-regulated by wild type Myc (Li et al., 1994; Lee et al., 1997), including the c-myc locus 
itself (Penn et al., 1990; Bush et al., 1998; Oster et al., 2003). Importantly, the biological function of the 
MB2 cannot be replaced by the strong transactivation domain of the viral transcription factor VP16 
(Brough et al., 1995). 
Much less is known about the central 240 amino acids of Myc. This region is less conserved, with the 
exception of a motif called Myc box 3 (MB3) that is found in all Myc proteins from insects to vertebrates 
(note that the term "Myc box 3" has been applied to a different region by Herbst et al., 2005; Cowling and 
Cole, 2006). Although MB3 resembles a PEST domain, and hence might be expected to contribute to the 
degradation of Myc protein, its deletion does not affect Myc’s half-life (Herbst et al., 2004); this region 
also does not seem to contribute to transcriptional regulation by Myc (Kato et al., 1990). To date, MB3 
has only been shown to be required for Myc’s ability to transform certain cell types (the rat fibroblast line 
Rat1a and primary chicken hematopoietic cells; Heaney et al., 1986; Biegalke et al., 1987; Stone et al., 
1987). However, given its high evolutionary conservation, we consider it likely that MB3 fulfills some 
additional essential functions that may not be evident in cultured cells in vitro - and the same might 
possibly hold true for other conserved domains as well.  
Therefore, we set out to address the importance of the conserved domains for Myc function in vivo in 
the context of intact tissues. We used Drosophila melanogaster, which contains a single Myc gene 
(diminutive or dm) that is functionally interchangeable with its vertebrate counterparts (Gallant et al., 
1996; Schreiber-Agus et al., 1997; Trumpp et al., 2001; Benassayag et al., 2005). Mutations in Myc 
impair growth, such that flies carrying hypomorphic Myc alleles (e.g. dmP0) are delayed in their 
development and eclose as small adults (Johnston et al., 1999), whereas dm4 mutant flies (null for Myc) 
fail to grow as larvae and die within a few days of hatching (Pierce et al., 2004; Pierce et al., 2008; 
Steiger et al., 2008). Conversely, overexpression of Myc promotes cellular growth (Johnston et al., 1999), 
endoreplication (Maines et al., 2004; Pierce et al., 2004), and apoptosis (De La Cova et al., 2004; 
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Montero et al., 2008). In the present study, we expressed wild type and mutant forms of Myc (carrying 
mutations in MB2, MB3, or the N-terminus) in vivo. These experiments revealed a strong requirement for 
the N-terminus for all Myc-dependent activities. Surprisingly, mutation of MB2 only weakened, but did 
not fully inactivate Myc function, such that an MB2-mutant form of Myc could rescue the survival of a 
sizable fraction of Myc-null mutant flies. Finally, deletion of MB3 only moderately affected several of 
Myc’s activities in vivo.  
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2 Materials and Methods 
2.1 Cloning and expression of Myc proteins 
A cDNA for wild type Myc with a triple HA-epitope at its N-terminus (Bellosta et al., 2005) was cloned 
into a pBS-vector carrying a single ΦC31 attB site, 5 UAS repeats, a hsp70 basal promoter, the SV40 
polyA signal, and mini-white as a marker (Bischof et al., 2007). By site-directed mutagenesis the 
following mutant derivatives were created (numbering relative to untagged Myc): MycΔN: lacking amino 
acids 1 – 65; MycMB2A: containing “AAAA” instead of “DCMW”; MycΔMB2: “GP” substituted for 
residues 68-84; MycΔMB3: “F” substituted for residues 405-422. The same cDNAs were also cloned 
directly under the control of the α-tubulin84B promoter (see Bellosta et al., 2005) into an analogous pBS-
vector lacking UAS- and hsp70-sequences. Full sequences are available upon request. 
2.2 Drosophila lines 
Transgenic flies were established by integrating the different attB plasmids into the attP landing site zh-
86Fb (Bischof et al., 2007; http://www.frontiers-in-genetics.org/), and confirmed by PCR. Source of 
additional flies: GAL4 drivers (Drosophila stock center at Bloomington), act-FRT-CD2-FRT-GAL4 
(Neufeld et al., 1998), GMR-FRT-w+-FRT-GAL4 (Brogiolo et al., 2001), tub-FRT-Myc-FRT-GAL4 (De 
La Cova et al., 2004), dmP0 (Johnston et al., 1999), dm2 (Maines et al., 2004), dm4 (Pierce et al., 2004), 
dm4 mnt1 (Pierce et al., 2008), dmPL35 & dmPG45 (Benassayag et al., 2005). 
2.3 Western blots & immunocytochemistry 
To document transgene expression in vivo, 20 wing imaginal discs of uncrowded wandering larvae 
carrying one copy of tub-HAMycmut were lysed directly in Laemmli sample buffer and analyzed by SDS-
PAGE and immunoblotting. Primary antibodies were: rabbit anti-HA epitope (Dunn Labortechnik 
GmbH), mouse anti-α-Tubulin (Sigma). Secondary antibodies were HRP-coupled anti-rabbit (GE 
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Healthcare) or anti-mouse (Jackson Immuno Research) and for detection the enhanced 
chemiluminescence kit (Amersham) was used. 
For TUNEL staining of wing imaginal discs, wandering third instar larvae were fixed in 4% 
paraformaldehyde for 20’, washed with 1x PBT (0.1% Tween-20 in PBS [130 mM NaCl, 7 mM 
Na2HPO4, 3 mM NaH2PO4]) for 20’, post-fixed in ethanol/PBS (2:1) for 5' at –20° C, washed with 3 
changes of 0.1% Tween-20/PBS over 15’, pre-treated with 10 mM sodium citrate (pH 6) for 30’ at 70° C, 
equilibrated in Equilibration Buffer (ApopTag Red In Situ Apoptosis Detection Kit, Chemicon) for 10’, 
then incubated with TdT enzyme (Chemicon kit) for 1 h at 37° C, Stop/Wash Solution (Chemicon kit) for 
10’, Rhodamine-coupled anti-DIG antibodies (Chemicon kit) for 30’, and 3 changes of 0.1% Tween-
20/PBS (containing 0.5 µg/ml Hoechst 33342 for the first step).  
For clonal area measurements, larvae carrying the act-FRT-CD2-FRT-GAL4 construct, UAS-GFP and 
the appropriate UAS-HAMycmut transgene, were heat-shocked for 10’ at 37° C in a water bath (at 48h 
AED), dissected 73 h later (at the wandering stage), fixed in 4% paraformaldehyde for 20’, and washed 
with 3 changes of PBT (containing 0.5 µg/ml Hoechst 33342 for the first step) over 60’.  
Wing discs were dissected and mounted in Vectashield Mounting Medium (Vectashield), and 
photographed on a Leica DMRA compound microscope at a 10x ocular magnification and analyzed with 
Adobe Photoshop. 
2.4 qRT-PCR 
Larvae were grown under uncrowded conditions, heat-shocked at wandering stage for 2 h at 37°C in a 
water bath, collected 8 h later into liquid nitrogen, and stored at -80°. To extract RNA, 10 male whole 
larvae were homogenized in 1 ml TRIZOL (Invitrogen) with a Polytron tissue homogenizer, following 
the manufacturers instructions. Upon precipitation, RNA was redissolved in 20 µl RNAse-free water and 
analyzed for its integrity on a Bioanalyzer (Agilent). Genomic DNA was eliminated using the Turbo 
DNAse free kit (Ambion) and cDNAs were synthesized from 1 µg of template RNA using the Omniscript 
kit (Qiagen). Parallel control reactions containing only RNA provided templates for “-RT” samples. 
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Quantitative real-time PCR (qRT-PCR) reactions were performed in triplicates on an ABI7900 Real Time 
PCR Instrument (Applied Biosystems), using the SYBR Green PCR Master Mix (Applied Biosystems). 
Data were analyzed with SDS 2.0 software (Applied Biosystems) and Microsoft Excel, using the ΔΔCt 
method and the average of the expression levels of actin5C, Rab6 and Sec24 as internal reference for each 
biological sample, with the values for “MycWT” set to 100%. 
Primer sequences: Rab6: 5’-TGCACGTGGCCAAGTCCTA & 5’-CAGCGAACGCGACTGCTA; 
Sec24 5’-CCACTCCCCTGCCATCCT & 5’-ACCCCAAACCCAGCAACA; CG5033: 5’-
TAACCGCTCGGCTTTAATTCA & 5’-CCCTTGCTCTTGGAGAATGG. The remaining primers and 
the PCR conditions have been described (Steiger et al., 2008). 
2.5 Analysis of adult flies 
Flies were kept on standard Drosophila medium and test crosses performed in climate-controlled 
chamber at 25°. 
Scanning electron microscope pictures were taken with a JEOL JSM-6360 LV microscope and a 
magnification of 180x. Flies were frozen at –20° C for at least one day, slowly defrosted at 0°C and 
directly used for electron microscopy. For determination of ommatidial size, the area of 20 centrally 
located ommatidia was determined from 5 flies of the same genotype using Adobe Photoshop. The same 
photomicrographs were also used to determine the total number of ommatidia per eye. Obvious fusions of 
two ommatidia were counted as two individual ommatidia.  
To determine adult weights, 1-2 day adult flies were frozen at –20° C for at least one day, defrosted at 
room temperature and weighed on a Mettler Toledo MX5 micro balance. 
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3 Results 
3.1 Transactivation potential of Myc mutants 
To investigate the in vivo roles of the most highly conserved domains of Myc, we mutated or deleted 
MB2, MB3 or the entire N-terminus and tagged the different variants with a triple HA-epitope at their N-
termini (Fig. 1A). Transgenes coding for the different constructs were established using the ΦC31 system 
for targeted transgenesis, thus ensuring equal mRNA expression levels for all mutants and eliminating 
potentially confounding integration site effects (Groth et al., 2004; Venken et al., 2006; Bischof et al., 
2007). Indeed, the different proteins were mostly expressed at similar levels (Fig. 1B), although repeated 
Western blots (n=12) revealed some variability in the levels of the different protein variants (with the 
ΔMB3 mutant occasionally [n=4] accumulating to higher levels than the other forms). As a first step to 
characterize the biological activities of these mutants, we monitored their ability to activate established 
endogenous Myc targets in a Myc-null mutant background. For this purpose, the transgenes were first 
combined with the Myc null allele dm4, a “tub-FRT-Myc-FRT-GAL4” transgene (which drives ubiquitous 
expression of a MycWT cDNA and thereby rescues the lethality of the dm4 allele; Bellosta et al., 2005) 
and hs-FLP. Following a massive heat-shock of 2 hours at 37°, virtually all cells have eliminated the 
rescuing Myc cDNA and express GAL4 instead (Hulf et al., 2005), which in turn drives the expression of 
the UAS-controlled transgenes. Eight hours later (before any overt signs of apoptosis; data not shown), 
total RNA was isolated and analyzed for the abundance of Myc and selected target genes. By this time, 
the mRNA levels for Myc and its RNA polymerase 2 transcribed targets Nnp1 and CG5033 (Hulf et al., 
2005) have significantly diminished, whereas the RNA polymerase 3 transcribed Myc targets tRNALeu and 
snoRNA U3 (Steiger et al., 2008) show considerable perdurance (see Sup. Fig. 1A, which also provides 
an independent partial repeat of Fig. 1C below). Introduction of MycΔN leads to little activation of these 
genes above background (Fig. 1C, compare with the “-“ sample expressing no transgene), but MycΔMB2 
partially activates Pol 2 transcribed Myc targets; MycΔMB3 is almost as active as MycWT towards Nnp1 
and CG5033, but (like MycΔN and MycΔMB2) has strongly reduced activity towards the Pol 3 
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transcribed Myc targets. Similar effects were observed in S2 cells, where the transiently expressed MB2 
and MB3 mutants were able to partially activate a Myc-dependent reporter, whereas MycΔN was inactive 
(Sup. Fig. 1B, C). Taken together, these data confirm that N-terminus and MB2 are important for Myc 
dependent transcription by Pol 2 and Pol 3 (consistent with published data for the vertebrate proteins), 
and they reveal that MB3 also has a role in transactivation, in particular for the activation of RNA 
polymerase 3. The molecular basis for this stronger effect on Pol 3 is unclear; the only Myc-interacting 
protein that is currently known to be specifically involved in Pol 3-dependent transcription in Drosophila, 
Brf (Steiger et al., 2008), binds with similar efficiency to both MycΔMB3 and MycWT (data not shown).  
3.2 Overexpression of Myc mutants in vivo 
Myc proteins are important both for normal development and tissue homeostasis, when they are 
expressed at physiological levels, and in the etiology of tumors, where they are frequently overexpressed. 
While Myc’s physiological activities can account for much of its potency as an oncoprotein, it is 
conceivable that Myc takes on additional, qualitatively different, functions when expressed at supra-
physiological levels. For these reasons, we wanted to investigate the activities of our Myc mutants first in 
overexpression situations, and second in the presence of amorphic Myc alleles, where the ability of the 
mutant proteins to substitute for endogenous Myc could be probed. 
First, we analyzed the ability of the different Myc mutants to promote growth upon overexpression. It 
has previously been shown that overexpression of MycWT under the control of GMR-GAL4 strongly 
increases the size of adult ommatidia (Secombe et al., 2007; Montero et al., 2008; Steiger et al., 2008); 
since this driver expresses GAL4 in eye imaginal discs from the late 3rd larval instar on, it mainly 
influences the final growth and differentiation phase of the eye cells, but not the proliferation of their 
precursors and the final number of ommatidia. Consistent with their transactivation abilities, the MB2 
mutants are still able to promote growth, albeit to a lesser extent than MycWT, and MycΔN is inactive in 
this assay (Fig. 2A, B). Surprisingly, MycΔMB3 increases ommatidial size more than MycWT and 
additionally induces considerable roughness of the eye. Such a morphology (caused by a combination of 
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excessive growth and apoptosis) is also observed when MycWT is expressed at higher levels (Steiger et 
al., 2008), indicating that MycΔMB3 is more active than MycWT in this assay, as a consequence of 
increased specific activity and/or higher levels of MycΔMB3.  
The different Myc mutants show similar growth-promoting abilities when over-expressed under the 
control of ap-GAL4 in the dorsal compartment of wing imaginal discs. The resulting size difference 
between the dorsal and the ventral compartments results in a moderate (ΔMB2, MB2A) or strong (WT) 
bending down of the adult wings (Fig. 2C). MycΔN again shows no activity, even though this bending 
provides a very sensitive read-out for growth inducers (see Montagne et al., 1999). MycΔMB3 reveals 
other phenotypes (Fig. 2C) that can also be observed upon overexpression of a different, stronger 
MycWT transgene (e.g. dissociation of the dorsal and ventral wing surface, necrotic patches; data not 
shown), and that suggest that the Myc-induced excessive apoptosis overwhelms its growth-promoting 
ability. Indeed, TUNEL staining of 3rd instar larval wing discs (Fig. 3) reveals that all Myc proteins 
except for MycΔN induce apoptosis (as previously reported for MycWT; Montero et al., 2008), but that 
MycΔMB3 clearly has the highest activity. Thus, like in the eye, the MycΔMB3 transgene is more active 
than MycWT in the wing. 
The experiments described so far document the effects of the different Myc mutants on final adult tissue 
size. To demonstrate directly to which extent Myc proteins promote the rate of cellular growth, we 
expressed the different proteins in clones of cells in wing imaginal discs carrying an “act-FRT-stop-FRT-
GAL4” cassette, a hs-FLP transgene and a UAS-GFP marker. Overexpression clones were induced by a 
10’ heat-shock at 37°, which drives the expression of FLP recombinase leading to the activation of GAL4 
in a few random cells of the disc, and analyzed 73 hours later (after 6 to 7 cell doublings). The 
coexpressed GFP allowed for the identification of the clones; since larval wing discs consist essentially of 
a monolayer of undifferentiated cells, the areas of such clones provide a good measure for their volume 
increase. Consistent with published observations (Johnston et al., 1999), MycWT overexpression strongly 
promotes clonal growth (Fig. 4A, B), and so does MycMB2A. As expected, MycΔN does not affect the 
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growth rate of these clones. However, MycΔMB3 significantly reduces clonal area, suggesting that its 
powerful pro-apoptotic ability (see Fig. 3) overcomes the proliferative capacity of these clones. 
Taken together, the overexpression studies demonstrate that the N-terminus is essential for Myc’s 
ability to promote growth, whereas a mutation or deletion of MB2 only moderately impairs Myc activity; 
loss of MB3 increases the biological activity of Myc (possibly in part by affecting the levels of Myc 
protein).  
3.3 Rescue of Myc mutant eyes by Myc protein mutants 
Normal eye development requires Myc, and hypomorphic or null alleles of Myc result in smaller eyes, 
composed of smaller and (for lethal alleles) fewer ommatidia (Bellosta et al., 2005; Steiger et al., 2008; 
Fig. 5). Therefore the eye constitutes a good organ for analyzing the normal biological activities of Myc 
proteins. To reveal the phenotype of such Myc mutant eyes without lowering Myc activity in the rest of 
the body (which would interfere with organismal viability), we combined the rescuing transgene “tub-
FRT-Myc-FRT-GAL4” with “ey-FLP”, resulting in elimination of the Myc cDNA and concomitant 
expression of GAL4 in precursors of the eye and head capsule. The FLP-mediated replacement of Myc 
with GAL4 is highly efficient, as shown in Sup. Fig. 2. We used this system to express the different Myc 
variants in eyes that were wild type for Myc or carried the null allele dm4. Importantly, transgene 
expression in this assay is maintained from early development to the terminal differentiation phase, and 
therefore affects both the final number and size of the resulting ommatidia. 
All Myc mutants significantly increase ommatidial size as compared to control, with the effects being 
largest in the dm4 background that lacks endogenous Myc altogether (Fig. 5A, B). Even MycΔN, which 
was inactive in all other assays, increases ommatidial size by 10% in a dm+ background; the difference to 
the GMR-driven overexpression experiment shown above is presumably due to the different expression 
dynamics of the two GAL4 drivers [GMR is not expressed in all cell types of the differentiating eye (Ellis 
et al., 1993), but tub should be ubiquitously expressed; furthermore level and duration of GAL4 
expression are likely to differ between the two systems]. The ΔN mutant also significantly increases the 
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number of ommatidia in dm4 mutant eyes (Fig. 5C, compare “-“ and “ΔN”), thus demonstrating its 
activity both during the earlier proliferative and the later differentiation phase. Note that we would not 
expect any Myc mutant to increase the number of ommatidia in dm+ eyes, since Myc overexpression does 
not increase cell division rates in wild type cells (Johnston et al., 1999). Instead, expression of the other 
Myc forms slightly or significantly reduces the number of ommatidia in this assay, reflecting the pro-
apoptotic activity of these proteins (Bellosta et al., 2005). As before, this effect is strongest for 
MycΔMB3, as can also been seen by the obvious roughness of the eyes expressing this mutant (Fig. 5A). 
Taken together, this experiment confirms the growth- and apoptosis-promoting capabilities of the 
different Myc mutants, and it shows that MycΔN also retains some activity.  
3.4 Organismal rescue of Myc mutants  
As a final, most stringent, functional assay we determined to which extent the different Myc mutants 
could drive the entire development. None of the Myc transgenes was able to rescue the lethal Myc alleles 
dm2 or dm4 when expressed under the control of the ubiquitous GAL4 drivers arm, da, or tub; presumably 
the resulting Myc expression was either too weak (with arm-GAL4) or too strong (when driven by da-
GAL4 or tub-GAL4 in a wild type background both MycWT and MycΔMB3 caused dominant lethality). 
Efficient rescue of lethality (to more than 50%) was only observed with the enhancer trap allele dmPG45, 
which is both mutant for Myc and expresses GAL4 in a Myc-like pattern (Benassayag et al., 2005), in 
combination with MycΔN, MycΔMB2 or MycMB2A, indicating that Myc mutants that lack either the N-
terminus or MB2 retain sufficient activity to complement the low levels of endogenous Myc in the dmPG45 
mutant. Neither MycWT nor MycΔMB3 efficiently rescued dmPG45, consistent with previous reports that 
a UAS-MycWT transgene does not rescue this allele but instead causes dominant lethality in a dmPG45/dm+ 
background (Benassayag et al., 2005), presumably because the GAL4/UAS system amplifies the 
transcriptional output of the Myc locus to lead to excessive expression of the UAS-transgene. An 
analogous amplification might explain the lethality of a MycWT transgene when expressed under the 
control of a tub-GAL4 driver, whereas a transgene expressing MycWT directly under tubulin control 
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causes no harm in flies and even rescues a Myc null mutant. Such considerations prompted us to generate 
a second series of transgenes, in which the expression of the different Myc mutants is controlled directly 
by α-tubulin regulatory sequences; these transgenes were integrated in the same chromosomal location as 
before using the ΦC31 system. All transgenes could be established, although tub-MycΔMB3 showed 
some dominant lethality in a dm+ background and could not be maintained as a homozygous line. Both 
MycWT and MycΔMB3 rescued the lethality of dm4 mutant flies (Fig. 6A, B), although the resulting 
adults were smaller than control (Fig. 6A, C). Expression of MycΔN did not lead to any escapers, but 
much to our surprise, a substantial fraction of MycΔMB2 expressing dm4 flies (15% of the expected 
number) developed to term when 2 copies of the transgene were present and eclosed as normally 
patterned adults (Fig. 6). This fraction increases to 39% when the Myc antagonist Mnt is simultaneously 
mutated, i.e. in a dm4 mnt1 background, where Myc targets have been shown to be partially derepressed 
(Pierce et al., 2008). Thus, MB2 is not absolutely required to promote the full development from egg to 
adult, even in the absence of any endogenous Myc protein. 
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4 Discussion 
4.1 Myc box 2 
Myc proteins show a comparatively low overall sequence conservation between the most distant known 
family members from insects and vertebrates, but they all contain a short, highly conserved sequence 
motif, the Myc box 2 (MB2). The very fact that this domain is conserved suggests an indispensable 
function, and MB2 has indeed been shown to play an essential role in different tissue culture based 
assays. However, the variety of cell types that have been tested in tissue culture (most frequently 
fibroblasts), as well as the types of biological read-outs that have been used (typically proliferation, 
apoptosis or transformation), are both limited. As Myc interacts with many different transcriptional co-
factors, we hypothesized that the proteins contacting MB2 might be important for the expression of only a 
subset of Myc’s targets, or essential only in certain cell types, or required for only certain biological 
processes. By expressing MB2-mutant forms of Myc in vivo, we exposed the proteins to a variety of 
different contexts. We expected that the mutants would be inactive in most situations, but possibly retain 
some activity in a particular assay. Unexpectedly however, MB2 mutants showed an intermediate activity 
in all our assays (often close to that of MycWT). Most strikingly, MycΔMB2 was able to rescue mutant 
animals lacking all endogenous Myc, which would otherwise all have died during development. This 
finding suggests that MB2 does not contribute a qualitatively unique and essential function to Myc, but 
instead may act to enhance Myc’s transcriptional output or modulate it in response to external signals. It 
further implies that no essential co-factor relies on MB2 for its interaction with Myc, either because no 
MB2-interacting protein is essential for Myc function, or because all MB2-interacting essential co-factors 
also contact Myc via additional redundant domains. At present we cannot address these possibilities 
experimentally, since no protein has been found to contact MB2 in Drosophila; two candidates we 
investigated (dGCN5 and Tip49/Pontin) bound Myc independently of the presence of MB2 (data not 
shown). Thus, we can only speculate about reasons for the partial dispensability of MB2; for example, the 
activation of a Myc target that normally relies on an MB2-dependent HAT might be partially taken over 
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by an MB2-independent HAT, or that such a Myc target gene might instead be activated by a histone 
acetylation-independent process, or that other targets might supplant the function of such genes. In either 
case, our observations provide an example of unexpected biological plasticity, considering the 
exceptional evolutionary conservation of this MB2. 
4.2 N-terminus 
By comparison, the elimination of the entire N-terminus has substantially more severe effects. 
Nevertheless, the MycΔN protein (which corresponds to the naturally occurring c-MycS variant in 
vertebrates) clearly retains some activity. Similar to human c-MycS (Benassayag et al., 2005), MycΔN 
can rescue the lethality of the dmPG45 allele; as dmPG45 is a hypomorphic (albeit lethal) Myc allele, some 
Myc activity must still be present in these flies and might cooperate with MycΔN in this rescue. However, 
MycΔN also significantly enhances the size and number of ommatidia that lack Myc altogether (Fig. 5), 
demonstrating that this mutant has the ability to stimulate cellular growth and proliferation on its own 
(although, like c-MycS, it cannot induce apoptosis – Fig. 3). This growth effect is comparatively weak 
and not seen in other overexpression experiments, though, essentially confirming studies of vertebrate 
Myc that have assigned an important biological role to this part of the protein. 
4.3 Myc box 3 
The function of the second highly conserved domain in Myc, MB3, is more ambiguous. MB3 resembles 
PEST motifs, but its deletion has no dramatic effect on Myc levels under normal culture conditions, 
suggesting that other evolutionary constraints are imposed on this domain. Indeed, the MycΔMB3 mutant 
has a lower transactivation potential than MycWT, in particular towards Pol3 transcribed genes, raising 
the possibility that this domain contacts some co-activators (that remain to be identified). In light of its 
reduced transcriptional activity, it is surprising that MycΔMB3 is more potent than MycWT in inducing 
apoptosis (in the developing wing) and growth (in the differentiating eye). At present we can only 
speculate that the deletion of MB3 might differentially affect the expression of certain Myc targets (as 
suggested by the stronger defect in activating Pol3 targets), and that certain Myc targets that are important 
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for the terminal size increase of ommatidia are still activated by this mutant (or that their expression is 
even enhanced at the expense of other targets). Such an “unbalanced” activation of Myc targets might 
also poise certain cells towards an apoptotic fate. In addition, we cannot exclude the possibility that a 
slightly increased stability of the MycΔMB3 mutant may also contribute to its increased in vivo activities. 
Finally, it should be noted that the sequence coding for MB3 straddles the junction between exons 2 and 3 
in all Myc genes (Fig. 1A), raising the possibility that some splice signals or another unknown structure of 
the Myc gene contribute to the evolutionary maintenance of MB3 – or alternatively, that the conservation 
of MB3 sequences has concomitantly fixed the exon boundaries in Myc. 
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Figure legends 
Figure 1. Transcriptional activity of Myc mutants. A, schematic representation of the Myc mutants 
used in this work. All constructs contain an N-terminal triple HA-tag, with the coordinates referring to the 
untagged Myc. The MB2 and MB3 sequences shown on the top are derived from human c-Myc (upper 
line) and Drosophila Myc (lower line); the dots in c-Myc represent a 6 residue acidic stretch missing in 
Drosophila Myc, and the vertical line shows the junction between exons 2 and 3 that is conserved in Myc 
genes. Uppercase letter designate identically conserved amino acids. In MycMB2A, the amino acids 
“DCMW” are replaced by “AAAA”. B, expression level of the HAMyc variants in wing imaginal discs. 
Wing imaginal discs of third instar larvae of the genotype “y w; tub-HAMyc” were collected at 5 days 
after egg deposition (AED) and processed for Western blot. Each lane contains the equivalent of 20 wing 
imaginal discs. The same blot was probed with anti-HA antibodies (top panel) to reveal HAMyc and with 
anti-α-Tubulin antibodies (bottom panel) as a loading control. C, expression of endogenous Myc targets 
in Myc-mutant larvae in response to the indicated transgenes. The Myc null mutation dm4 was exposed, 
and the transgene expression triggered by a heat-shock. Shown are the averages (± standard deviations) of 
two biologically independent samples (except MycΔN: only one sample). Genotypes in C are “w dm4 
tub>Myc>GAL4 hs-FLP/Y; X”, where “X” corresponds to an empty vector transgene (sample “-“) or a 
UAS-HAMycmut transgene as indicated. 
Figure 2: Effect of Myc overexpression on ommatidial size and wing shape. A, scanning electron 
micrographs of representative eyes containing single UAS-transgenes with the indicated Myc mutants 
under the control of GMR-GAL4. The scale bars correspond to 100 µm. B, average ommatidial area (± 
standard deviation) for the indicated genotypes (corresponding to the eyes in panel A), calculated from 20 
centrally located ommatidia from 5 independent eyes per genotype. “**” indicates genotypes whose 
ommatidia are significantly larger than “-“ ommatidia with p<0.01. C, representative frontal views of 
adult wings of flies heterozygous for ap-GAL4 (driving GAL4 expression in the dorsal wing 
compartment) and one UAS-transgene coding for the indicated Myc version. 
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Figure 3: Induction of apoptosis by overexpressed Myc. TUNEL-staining of representative third 
instar larval wing imaginal discs carrying one copy of ap-GAL4 and one UAS-transgene coding for the 
indicated Myc version. The TUNEL-positive region in the panel showing a ΔMB3 wing disc provides a 
good reflection of the GAL4 expressing domain.  
Figure 4: Stimulation of clonal growth by overexpressed Myc. A, third instar larval wing imaginal 
discs with typical 73 hours old clones (marked in bright white) expressing GFP and the indicated Myc 
variant. To reveal nuclei, the discs have been stained with Hoechst 33342 dye. B, average clonal area 
from discs corresponding to the genotypes shown in panel A. Number of analyzed clones (in parentheses 
the corresponding genotype): 50 (-), 45 (WT), 42 (ΔN), 53 (MB2A), 40 (ΔMB3). 
Figure 5: Effects of continuous Myc expression on ommatidial size and number. A, scanning 
electron micrographs of representative eyes of the indicated genotype. Sex chromosomes are “y w tub-
FRT-Myc stop-FRT-GAL4 ey-FLP/Y” (labeled “dm+” on the left) or “w dm4 tub-FRT-Myc stop-FRT-
GAL4 ey-FLP/Y” (labeled “dm4”); all flies are males, i.e. contain no additional dm+ allele; in addition, 
these flies carry one UAS-transgene coding for the Myc variant indicated below the picture. B, average 
ommatidial area (± standard deviation) for the indicated genotypes (corresponding to the eyes in panel A), 
calculated from 20 centrally located ommatidia from 5 independent eyes per genotype. The reference 
genotypes for the “dm+” and the “dm4” series are “dm+; -“ and “dm4; -“, respectively; note that “dm4; -“ 
ommatidia are 23% smaller than “dm+; -“ ommatidia. All areas are significantly larger than the 
corresponding “-“ control with p<0.01 (Students t-test), except for “dm+; ΔN” where p=0.03. C, average 
ommatidial number (± standard deviation) for the indicated genotypes (corresponding to the eyes in panel 
A). Asterisks indicate significance of difference to the corresponding “-“ genotype, with p<0.05 (*) and 
p<0.01 (**). 
Figure 6: Rescue of a Myc-null mutation by the expression of Myc protein mutants under the 
direct control of the tubulin-promoter. A, dissecting microscope pictures of rescued Myc-null mutant 
adult males expressing two copies of the indicated transgenes. B, relative survival rate for the indicated 
genotypes (the expected number of “w dm4/Y” or “w dm4 dmnt1/Y” males carrying one or two copies of 
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the indicated “tub-HAMycmut” transgenes was calculated from the number of recovered dm4/dm+ 
heterozygous females from the same cross, and set to 100%). For each genotype 300-800 flies in total 
were scored (except for w dm4/Y; tub-HAMycΔMB3/+: 91 flies, w dm4 dmnt1/Y; tub-HAMycΔN: 64 flies, 
w dm4 dmnt1/Y; tub-HAMycWT: 229 flies), of which rescued Myc-mutant made up one quarter (one eight 
for the tub-HAMycΔMB3 transgenes). C, average weight of at least 13 male flies per genotype (except 
dm4/Y; tub-HAMycΔMB3/+: 8 flies); the error bars indicate standard deviation. The control genotype is 
“y w”. 









Supplemental Methods 
Drosophila S2 cells were cultured at 24°C in 1x Schneider`s Drosophila medium (Gibco/BRL), 
supplemented with 10% fetal bovine serum, 1% Penicillin/Streptomycin. At 48 h after transfection, cells 
were harvested, washed with 1xPBS, lysed in Laemmli sample buffer and analyzed by SDS-PAGE and 
immunoblotting. 
Reporter assays were carried out as previously described (Hulf et al. 2005). Briefly, 1.3x106 cells/well 
of a 24-well cell culture plate were transfected with 0.65 ml serum-free medium containing 4.2 µl 
cellfectin (Invitrogen), 0.08 µg dsRNA targeting the 5’ UTR of Myc (not recognizing the HAMyc-
constructs), and 2.6 µg plasmid DNA (consisting of a 1:1 mix of “CG5033wt-Renilla luciferase” and 
“CG5033ΔEbox-firefly luciferase” reporters, tub-GAL4 and UAS-plasmids). After 15-16 h, 0.65 ml 
complete media was added; 24h later, cells were washed in 1xPBS, lysed in 1x Passive Lysis Buffer 
(Dual-Luciferase kit, Promega), and relative reporter expression determined on a Wallac luminometer. 
Supplemental figure legends 
Supplemental figure 1: Transcriptional activity of Myc variants in S2 cells and in vivo. A, 
expression of endogenous Myc targets in Myc-mutant larvae in response to the indicated transgenes. 
Analogous experiment to the one shown in Fig. 1C (shown are averages ± standard deviations of two 
additional  biologically independent samples). The “no hs” samples contain UAS-HAMycWT but did not 
receive any heat-shock; the other samples are as indicated in the legend to Fig. 1C. B, Western blot of 
Drosophila S2 cells transiently transfected with UAS-plasmids coding for the indicated HAMyc variants 
together with a tub-GAL4 plasmid. The cells were lysed at 48 hours after transfection. The same blot was 
probed with anti-HA antibodies (top panel) to reveal HAMyc and with anti-α-Tubulin antibodies (bottom 
panel) as a loading control. C, Effect of Myc variants on a reporter gene in S2 cells. Endogenous Myc 
was down-regulated with RNAi in S2 cells and the indicated Myc mutants were expressed instead. The 
graph shows the relative activity of the co-transfected luciferase reporter (Renilla luciferase activity, 
controlled by the wild type CG5033 promoter, divided by firefly luciferase activity, controlled by a 
mutant CG5033 promoter lacking the sole Myc binding site), with the relative activity of MycWT set to 
100%; shown are the averages (± standard deviations) of 2 independent transfections from a 
representative experiment. 
Supplemental Figure 2: Efficiency of the ey-FLP system. Red ommatidia in either panel retain the 
“FRT-w+ stop-FRT” cassette and express the rescuing Myc cDNA, whereas the white ommatidia lack this 
cassette and the Myc cDNA, and hence expose the dm4 mutant. This picture also reveals the eye size 
reduction caused by the loss of Myc. Genotypes: 1, “w dm4 tub-FRT-Myc stop-FRT-GAL4 ey-FLP/Y; 
GMR-FRT-w+ stop-FRT-GAL4/+”; 2, “w dm4 tub-FRT-Myc stop-FRT-GAL4 hs-FLP/Y; GMR-FRT-w+ 
stop-FRT-GAL4/+”. 


